Comment on “Impact of EUCAST rapid antimicrobial susceptibility testing (RAST) on management of Gram-negative bloodstream infection”-Reference-Cited by-同舟云学术

Comment on “Impact of EUCAST rapid antimicrobial susceptibility testing (RAST) on management of Gram-negative bloodstream infection”

Published:2023-03 Issue:2 Volume:53 Page:104668
ISSN:2666-9919
Container-title:Infectious Diseases Now
language:en
Short-container-title:Infectious Diseases Now

Author:

Sajid Samar^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference6 articles.

1. Impact of EUCAST rapid antimicrobial susceptibility testing (RAST) on management of Gram-negative bloodstream infection;Cardot Martin;Infect Dis Now,2022

2. The Effect of Molecular Rapid Diagnostic Testing on Clinical Outcomes in Bloodstream Infections: A Systematic Review and Meta-analysis;Timbrook;Clin Infect Dis,2017

3. Trends in Antibiotic Consumption and Resistance in France Over 20 Years: Large and Continuous Efforts but Contrasting Results. Open Forum;Carlet;Infect Dis,2020

4. Multicentre Evaluation of the EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) Extending Analysis to 16–20 Hours Reading Time;Bianco;Antibiotics (Basel),2022

5. Åkerlund A, Jonasson E, Matuschek E, Serrander L, Sundqvist M, Kahlmeter G; RAST Study Group. EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories. J Antimicrob Chemother. 2020 Nov 1;75(11):3230-3238. doi: 10.1093/jac/dkaa333.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to comments on “Impact of EUCAST rapid Antimicrobial Susceptibility testing (RAST) on management of Gram-negative bloodstream infection”;Infectious Diseases Now;2023-03